These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21844308)

  • 21. Current research on drugs and vaccines for fighting bird flu.
    Wiwanitkit V
    Trans R Soc Trop Med Hyg; 2007 Dec; 101(12):1171-2. PubMed ID: 17655895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice.
    Sidwell RW; Barnard DL; Day CW; Smee DF; Bailey KW; Wong MH; Morrey JD; Furuta Y
    Antimicrob Agents Chemother; 2007 Mar; 51(3):845-51. PubMed ID: 17194832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimum dataset needed for confirmed human H5N1 cases.
    Bird SM; Farrar J
    Lancet; 2008 Aug; 372(9640):696-7. PubMed ID: 18706687
    [No Abstract]   [Full Text] [Related]  

  • 24. Oseltamivir resistance during treatment of influenza A (H5N1) infection.
    de Jong MD; Tran TT; Truong HK; Vo MH; Smith GJ; Nguyen VC; Bach VC; Phan TQ; Do QH; Guan Y; Peiris JS; Tran TH; Farrar J
    N Engl J Med; 2005 Dec; 353(25):2667-72. PubMed ID: 16371632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses.
    Govorkova EA; Leneva IA; Goloubeva OG; Bush K; Webster RG
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2723-32. PubMed ID: 11557461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuraminidase inhibitors and their role in avian and pandemic influenza.
    Crusat M; de Jong MD
    Antivir Ther; 2007; 12(4 Pt B):593-602. PubMed ID: 17944267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of antiviral effectiveness in influenza virus A subtype H5N1.
    Chan PK; Lee N; Zaman M; Adisasmito W; Coker R; Hanshaoworakul W; Gasimov V; Oner AF; Dogan N; Tsang O; Phommasack B; Touch S; Bamgboye E; Swenson A; Toovey S; Dreyer NA
    J Infect Dis; 2012 Nov; 206(9):1359-66. PubMed ID: 22927451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oseltamivir resistance in influenza A (H5N1) infection.
    Gupta RK; Nguyen-Van-Tam JS
    N Engl J Med; 2006 Mar; 354(13):1423-4; author reply 1423-4. PubMed ID: 16571890
    [No Abstract]   [Full Text] [Related]  

  • 29. The critically ill avian influenza A (H5N1) patient.
    Arabi Y; Gomersall CD; Ahmed QA; Boynton BR; Memish ZA
    Crit Care Med; 2007 May; 35(5):1397-403. PubMed ID: 17414089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza in Canada: 2006-2007 season.
    Reyes F; Aziz S; Li Y; Macey JF; Winchester B; Garner M; Huston P; King A
    Can Commun Dis Rep; 2008 Mar; 34(3):1-25. PubMed ID: 18404807
    [No Abstract]   [Full Text] [Related]  

  • 31. Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza.
    Taylor WR; Thinh BN; Anh GT; Horby P; Wertheim H; Lindegardh N; de Jong MD; Stepniewska K; Hanh TT; Hien ND; Bien NM; Chau NQ; Fox A; Ngoc NM; Crusat M; Farrar JJ; White NJ; Ha NH; Lien TT; Trung NV; Day N; Binh NG
    PLoS One; 2008; 3(10):e3410. PubMed ID: 18923671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlling immune response may cut bird flu death rate.
    Pearson H
    Nat Med; 2006 Oct; 12(10):1105. PubMed ID: 17128448
    [No Abstract]   [Full Text] [Related]  

  • 33. Managing seasonal influenza: oseltamivir treatment policy in indonesia?
    Kosasih H; Bratasena A; Pangesti K; Laras K; Samaan G
    Acta Med Indones; 2014 Jan; 46(1):58-65. PubMed ID: 24760811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [When the Avian virus (H5N1) become resistant to Tamiflu and the resulting consequences].
    Nau JY
    Rev Med Suisse; 2006 Jan; 2(48):171. PubMed ID: 16463806
    [No Abstract]   [Full Text] [Related]  

  • 35. Foreword: this issue of the Seton Hall Law Review presents contributions to Preparing for Pharmaceutical Response to Pandemic Influenza, a two-day Symposium held at Seton hall University School of Law in the fall of 2008.
    Seton Hall Law Rev; 2009; 39(4):1103-9. PubMed ID: 20718129
    [No Abstract]   [Full Text] [Related]  

  • 36. [Neuraminidase inhibitors in prophylaxis and treatment of influenza].
    Nitsch-Osuch A; Brydak LB; Wardyn AK
    Pol Merkur Lekarski; 2008 Jul; 25(145):67-73. PubMed ID: 18839619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiviral treatment of patients with oseltamivir-resistant and oseltamivir-susceptible seasonal Influenza A (H1N1) infection during the 2007-2008 influenza season in the United States.
    Dharan NJ; Gubareva LV; Klimov AI; Fiore AE; Bresee JS; Fry AM
    Clin Infect Dis; 2010 Feb; 50(4):621-2. PubMed ID: 20095841
    [No Abstract]   [Full Text] [Related]  

  • 38. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
    Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
    Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparing for pandemic influenza: should hospitals stockpile oseltamivir?
    Cinti S; Chenoweth C; Monto AS
    Infect Control Hosp Epidemiol; 2005 Nov; 26(11):852-4. PubMed ID: 16320980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [No evidence of fewer influenza complications with oseltamivir].
    Bonneux L
    Ned Tijdschr Geneeskd; 2009; 153():A1127. PubMed ID: 19857319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.